Twenty Years of Phase III Trials for Patients With Extensive-Stage Small-Cell Lung Cancer: Perceptible Progress

Journal of Clinical Oncology - United States
doi 10.1200/jco.1999.17.6.1794
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients With Extensive-Stage Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2009English

Phase II Trial of Sunitinib Maintenance Therapy After Platinum-Based Chemotherapy in Patients With Extensive-Stage Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2017English

Which Patients With Stage III Non-Small Cell Lung Cancer Should Undergo Surgical Resection?

Oncologist
Cancer ResearchMedicineOncology
2005English

The Prognostic Role of Circulating CD8+ T Cell Proliferation in Patients With Untreated Extensive Stage Small Cell Lung Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer

JAMA Oncology
Cancer ResearchOncology
2019English

Progress in the Management of Limited-Stage Small Cell Lung Cancer

Cancer
Cancer ResearchOncology
2013English

P2.12-03 Phase I/Ii Trial of 177Lu-Dota0-Tyr3-Octreotate (Lutathera) and Nivolumab for Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Phase II Study of AT-101 (Gossypol) in Chemotherapy-Sensitive Recurrent Extensive-Stage Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy